|
| Wednesday, 15 July 2020, 14:21 HKT/SGT | |
| |
|
|
|
|
| Empowers its European Staff to Capture Advanced Medical Knowledge, Promotes Innovation in Technology, and Enhances the Quality and Service Standard of the Refractive Field |
HONG KONG, July 15, 2020 - (ACN Newswire) - EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", stock code: 1846), a well-established leading ophthalmic medical group, is pleased to announce that Dr. Burkhard Dick ("Dr. Dick") has joined The EuroEyes International Medical Advisory Board. In the future. He will strive to promote continued medical education for European staff of the Group, foster innovation in technology and raise the quality and service standard of the refractive field.
 | | Dr. Burkhard Dick |
As one of the most influential surgeons who pioneered bladeless laser cataract surgery in Europe, Dr. Dick has a renowned reputation in the global ophthalmology community, serving as a regular lecturer at international meetings, such as the European Society of Cataract & Refractive Surgeons, the Deutsche Ophthalmologische Gesellschaft, the Deutschen Ophthalmochirurgen (DOC), the Deutschsprachige Gesellschaft fur Intraokularlinsen-Implanation und Refraktive Chirurgie, and the American Society of Cataract and Refractive Surgery. He has instructed fellows from 38 different countries in state-of-the-art cataract, refractive, glaucoma, and vitreoretinal surgery. In the "Power List 2018" ranking of the world's most influential ophthalmologists by the publication, The Ophthalmologist, Dr. Dick was listed among the Top 20, and he has been in the Top 50 several times before.
As the most influential ophthalmologist in the world, Dr. Dick joined the eye hospital of the University of Mainz in 1996 where he became a professor in 2003. In 2006, Dr. Dick was appointed as the chair of the department of ophthalmology at the University of Bochum and director of the University Eye Clinic, conducting R&D and promoting the cataract and refractive treatment, and leading the team to establish an internationally renowned ophthalmology clinic with outstanding achievements.
During his 30 years of practice, Dr. Dick persistently pursued more advanced and effective surgical techniques to promote the development of ophthalmology medical education.
Dr. Jorn Slot Jorgensen, executive director, chairman of the board of directors, and chief executive officer of EuroEyes, said: "We are excited that Dr. Burkhard Dick joins the EuroEyes international medical advisory board. EuroEyes plans to introduce more advanced vision correction technologies and equipment in the future. Leveraging Dr. Dick's, one of the pioneers in the industry, excellent and rich experience in surgery and R&D, we are confident to enhance the Group's comprehensive strength, promote technological innovation, and improve medical quality and service standards, as well as provide European and Chinese customers with the world's leading vision correction surgery, brings the best returns to our shareholders and investors."
Topic: Press release summary
Sectors: Daily Finance, Healthcare & Pharm, Funds & Equities
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
|
|
|
|
Latest Press Releases
Kraft Heinz, Braskem, and Tenaris to headline OMP Conference Sao Paulo 2026
Feb 18, 2026 13:21 HKT/SGT
|
|
|
Supported by U.S. Polo Assn., the 2026 U.S. Open Women's Polo Championship(R) Concludes with Victory Eastern Hay the Champion
Feb 18, 2026 13:20 HKT/SGT
|
|
|
IDC MarketScape names Hitachi Energy a Leader in Asset Performance Management for Worldwide Utilities
Wednesday, February 18, 2026 9:51:00 AM
|
|
|
Fujitsu named to FORTUNE Magazine's list of 'World's Most Admired Companie's for eighth year running
Wednesday, February 18, 2026 9:41:00 AM
|
|
|
Bioxytran, Inc. Announces Commercial Distribution Agreement with Khoury Medical LTD for A-SUQAR Dietary Supplement
Feb 17, 2026 21:00 HKT/SGT
|
|
|
Austral Gold Announces A$8.456 million Strategic Placement
Feb 17, 2026 20:29 HKT/SGT
|
|
|
Fujitsu automates entire software development lifecycle with new AI-Driven Software Development Platform
Tuesday, February 17, 2026 11:21:00 AM
|
|
|
Anson Resources to Commence Drilling at Yellow Cat Uranium-Vanadium Project, Utah USA
Feb 17, 2026 07:00 HKT/SGT
|
|
|
Snow master Evans leads 1-2-3-4 finish for TGR-WRT
Monday, February 16, 2026 2:24:00 PM
|
|
|
Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Novel Orexin Receptor Agonist E2086 for Narcolepsy
Monday, February 16, 2026 1:03:00 PM
|
|
|
|
|
More Press release >> |
|
 |
|
 |
|
